Expression of the CD44 and matrix metalloproteinase 3 were examined in 43 cases of breast carcinoma, Immunohistochemical staining with CD44 antibodies demonstrated diffuse cytoplasmic positivity in tumor cells of intraductal and invasive
carcinoma.
Matrix metalloproteinase 3 was present in invasive cancer cells and surronding stromal cells. Expression of the CD44 and matrix metalloproteinase 3 were moderately correlated. Expression of the CD44 was associated with the large size of primary
tumor(≥2cm), the histologic grade by Bloom-Richardson, the presence of metastatic node, and the clinical stage. Overall five-year survival rate in 43 patients was 74.0±9.6% and the disease free survival curve showed significant difference
according to
the expression of CD44. However, the expression of matrix metalloproteinase 3 was not associated with variable prognostic factors and disease free survival.
From this study, it is concluded that expression of the CD44 and matrix metalloproteinase 3 were associated with invasion of breast cancer and expression of the CD44 could be used as a prognostic indicator in breast cancers. However, the
expression
of
matrix metal-loproteinase 3 had the limited value.
|